Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,888 | 209 | 88.8% |
| Education | $491.27 | 15 | 11.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $645.38 | 34 | $0 (2023) |
| Astellas Pharma US Inc | $628.66 | 22 | $0 (2024) |
| Exeltis, USA Inc. | $505.11 | 20 | $0 (2024) |
| PFIZER INC. | $252.03 | 16 | $0 (2024) |
| Agile Therapeutics, Inc. | $202.70 | 11 | $0 (2024) |
| TherapeuticsMD, Inc. | $189.15 | 12 | $0 (2022) |
| Allergan, Inc. | $186.04 | 8 | $0 (2020) |
| Evofem Biosciences, Inc. | $180.56 | 10 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $148.68 | 9 | $0 (2020) |
| Lupin Inc. | $116.07 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $523.81 | 24 | Astellas Pharma US Inc ($160.98) |
| 2023 | $669.46 | 32 | Astellas Pharma US Inc ($156.78) |
| 2022 | $703.28 | 35 | ABBVIE INC. ($151.03) |
| 2021 | $572.74 | 32 | AbbVie Inc. ($153.63) |
| 2020 | $406.26 | 16 | Exeltis, USA Inc. ($186.15) |
| 2019 | $617.08 | 34 | Lupin Inc. ($97.43) |
| 2018 | $556.68 | 33 | AbbVie, Inc. ($99.48) |
| 2017 | $329.68 | 18 | Allergan Inc. ($90.58) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Biological | ||||||
| 11/21/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: WOMENS HEALTH | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: VACCINE | ||||||
| 10/16/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: CONTRACEPTIVE | ||||||
| 09/27/2024 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 09/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Biological | ||||||
| 09/19/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $17.60 | General |
| 09/11/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: HORMONE THERAPY | ||||||
| 08/14/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $17.71 | General |
| 07/17/2024 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 06/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Biological | ||||||
| 06/13/2024 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 06/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: VACCINE | ||||||
| 05/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Biological | ||||||
| 05/10/2024 | PFIZER INC. | MYFEMBREE (Drug) | Education | In-kind items and services | $19.27 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 04/23/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $17.34 | General |
| 04/17/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $69.99 | General |
| 03/26/2024 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 03/20/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: CONTRACEPTIVE | ||||||
| 03/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Biological | ||||||
| 03/12/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: WOMENS HEALTH | ||||||
| 03/01/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: ETONOGESTREL | ||||||
| 02/06/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: CONTRACEPTIVE | ||||||
| 11/29/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,944 | 2,019 | $458,238 | $130,182 |
| 2022 | 11 | 2,279 | 2,440 | $518,591 | $153,631 |
| 2021 | 16 | 1,834 | 1,977 | $367,101 | $118,060 |
| 2020 | 13 | 1,559 | 1,629 | $267,448 | $89,170 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 280 | 296 | $78,117 | $32,562 | 41.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 210 | 210 | $79,575 | $31,286 | 39.3% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 284 | 300 | $133,914 | $27,043 | 20.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 238 | 238 | $31,049 | $11,257 | 36.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 217 | 217 | $34,707 | $11,008 | 31.7% |
| 76376 | 3d radiographic procedure | Office | 2023 | 271 | 285 | $60,970 | $6,538 | 10.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 58 | $17,436 | $4,653 | 26.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 73 | 87 | $13,138 | $3,865 | 29.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 301 | 316 | $4,740 | $1,078 | 22.7% |
| 58100 | Biopsy of lining of uterus | Office | 2023 | 12 | 12 | $4,590 | $891.42 | 19.4% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 312 | 344 | $90,389 | $39,153 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 224 | 224 | $84,501 | $34,435 | 40.8% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 319 | 352 | $156,456 | $33,770 | 21.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 241 | 241 | $38,306 | $12,707 | 33.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 242 | 242 | $31,376 | $12,022 | 38.3% |
| 76376 | 3d radiographic procedure | Office | 2022 | 305 | 337 | $71,774 | $7,590 | 10.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 75 | $21,545 | $6,476 | 30.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 84 | 106 | $15,932 | $5,220 | 32.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 445 | 486 | $7,268 | $1,667 | 22.9% |
| 88143 | Pap test, manual screening and rescreening | Office | 2022 | 22 | 22 | $770.00 | $499.06 | 64.8% |
| 81025 | Urine pregnancy test | Office | 2022 | 11 | 11 | $275.00 | $93.26 | 33.9% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 254 | 291 | $76,798 | $33,381 | 43.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 184 | 184 | $69,494 | $29,116 | 41.9% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 126 | 129 | $57,583 | $13,231 | 23.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 224 | 224 | $35,608 | $11,989 | 33.7% |
About Dr. Dawn Torre, MD
Dr. Dawn Torre, MD is a Gynecology healthcare provider based in Garden City, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700887270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dawn Torre, MD has received a total of $4,379 in payments from pharmaceutical and medical device companies, with $523.81 received in 2024. These payments were reported across 224 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,888).
As a Medicare-enrolled provider, Torre has provided services to 7,616 Medicare beneficiaries, totaling 8,065 services with total Medicare billing of $491,043. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Gynecology
- Location Garden City, NY
- Active Since 08/09/2005
- Last Updated 04/30/2025
- Taxonomy Code 207VG0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700887270
Products in Payments
- SLYND (Drug) $389.68
- LO LOESTRIN FE (Drug) $379.84
- MYFEMBREE (Drug) $206.42
- Twirla (Drug) $202.70
- Veozah (Drug) $149.86
- PREMARIN (Drug) $148.64
- ANNOVERA (Drug) $145.35
- Phexxi (Drug) $127.91
- INTRAROSA (Drug) $119.78
- Orilissa (Drug) $117.29
- Xulane (Drug) $102.61
- ORIAHNN (Drug) $102.30
- Vitafol Ultra (Drug) $100.14
- SOLOSEC (Drug) $97.43
- LILETTA (Drug) $82.85
- Balcoltra (Drug) $79.09
- ORILISSA (Drug) $77.50
- MYRBETRIQ (Drug) $76.81
- Paragard (Device) $74.52
- Myrbetriq (Drug) $74.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecology Doctors in Garden City
Dr. Matthew Dilena, M.d, M.D
Gynecology — Payments: $7,269
Marc Behar, Md, MD
Gynecology — Payments: $6,013
Dr. Salvatore Lopresti, M.d, M.D
Gynecology — Payments: $5,667
Dr. Robert Nadell, M.d, M.D
Gynecology — Payments: $5,499
Jeffrey Miller, M.d, M.D
Gynecology — Payments: $4,897